Super Religare Laboratories (formerly SRL Ranbaxy), is planning to come up with an IPO of 2.8 crore Equity Shares having a Face Value of Rs.10/- each. Super Religare is one of the leading diagnostics services companies in India. SRL provides service in the field of Laboratory Medicine and Clinical Trials in India as well as in our neighboring Asian countries
The issue shall constitute 35% of the fully diluted post-issue paid up capital of the company. Nomura Financial Advisory & Securities (India) Pvt Ltd, Kotak Mahindra Capital Company Limited and Religare Capital Markets Limited are the Book Running Lead Managers to the issue
Check back Indian IPO Blog for the latest updates on Super Religare Laboratories IPO!
The issue shall constitute 35% of the fully diluted post-issue paid up capital of the company. Nomura Financial Advisory & Securities (India) Pvt Ltd, Kotak Mahindra Capital Company Limited and Religare Capital Markets Limited are the Book Running Lead Managers to the issue
Check back Indian IPO Blog for the latest updates on Super Religare Laboratories IPO!
No comments:
Post a Comment